We are live on ! Find out more
FEG

Financial Enhancement Group Portfolio holdings

AUM $839M
1-Year Est. Return 18.63%
This Fund
S&P 500
This Quarter Est. Return
+1.08%
1 Year Est. Return
+18.63%
3 Year Est. Return
+57.48%
5 Year Est. Return
+65.82%
10 Year Est. Return
+209.3%
AUM
$290M
AUM Growth
+$6.74M
Cap. Flow
+$5.8M
Cap. Flow %
2%
Top 10 Hldgs %
52.55%
Holding
285
New
19
Increased
58
Reduced
49
Closed
26

Top Buys

Rank Stock Value
1
FTSM icon
First Trust Enhanced Short Maturity ETF
FTSM
+$15.5M
2
FBT icon
First Trust NYSE Arca Biotechnology Index Fund
FBT
+$5.68M
3
V icon
Visa
V
+$5.51M
4
SPIP icon
State Street SPDR Portfolio TIPS ETF
SPIP
+$1.55M
5
USMF icon
WisdomTree US Multifactor Fund
USMF
+$1.17M

Top Sells

Rank Stock Value
1
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$8.67M
2
NOC icon
Northrop Grumman
NOC
+$6.4M
3
C icon
Citigroup
C
+$5.87M
4
CMI icon
Cummins
CMI
+$5.39M
5
SPEM icon
State Street SPDR Portfolio Emerging Markets ETF
SPEM
+$5.36M

Sector Composition

Rank Sector Weight
1 Technology 7.86%
2 Financials 5.72%
3 Consumer Discretionary 3.25%
4 Energy 2.39%
5 Healthcare 1.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLX icon
201
Clorox
CLX
$11.7B
$6K ﹤0.01%
44
-19
-30% -$2.35K
IWD icon
202
iShares Russell 1000 Value ETF
IWD
$81.8B
$6K ﹤0.01%
52
– –
LYG icon
203
Lloyds Banking Group
LYG
$90.7B
$6K ﹤0.01%
1,939
– –
BP icon
204
BP
BP
$114B
$5K ﹤0.01%
106
-2
-2% -$84
BUD icon
205
AB InBev
BUD
$166B
$5K ﹤0.01%
50
– –
DTE icon
206
DTE Energy
DTE
$29.5B
$5K ﹤0.01%
52
– –
GLD icon
207
SPDR Gold Trust
GLD
$133B
$5K ﹤0.01%
45
-1
-2% -$124
KEY icon
208
KeyCorp
KEY
$24.2B
$5K ﹤0.01%
265
– –
MRSH
209
Marsh
MRSH
$91.4B
$5K ﹤0.01%
58
– –
NVDA icon
210
NVIDIA
NVDA
$4.72T
$5K ﹤0.01%
800
-40,560
-98% -$246K
PFE icon
211
Pfizer
PFE
$142B
$5K ﹤0.01%
158
– –
SWBI icon
212
Smith & Wesson
SWBI
$669M
$5K ﹤0.01%
572
– –
RF icon
213
Regions Financial
RF
$26.3B
$4K ﹤0.01%
231
– –
VGLT icon
214
Vanguard Long-Term Treasury ETF
VGLT
$10.1B
$4K ﹤0.01%
50
– –
MXIM
215
DELISTED
Maxim Integrated Products
MXIM
$4K ﹤0.01%
73
– –
GM.WS.B
216
DELISTED
General Motors Company
GM.WS.B
$4K ﹤0.01%
163
+37
+29% +$804
CELG
217
DELISTED
Celgene Corp
CELG
$4K ﹤0.01%
50
– –
BRW
218
Saba Capital Income & Opportunities Fund
BRW
$342M
$3K ﹤0.01%
250
– –
CSQ icon
219
Calamos Strategic Total Return Fund
CSQ
$3.21B
$3K ﹤0.01%
223
-83,334
-100% -$1.03M
JNPR
220
DELISTED
Juniper Networks
JNPR
$3K ﹤0.01%
100
– –
SLV icon
221
iShares Silver Trust
SLV
$28.6B
$3K ﹤0.01%
180
– –
YUMC icon
222
Yum China
YUMC
$15.9B
$3K ﹤0.01%
75
– –
CMI icon
223
Cummins
CMI
$87.3B
$2K ﹤0.01%
13
-36,019
-100% -$5.39M
DBA icon
224
Invesco DB Agriculture Fund
DBA
$1.23B
$2K ﹤0.01%
87
– –
DBB icon
225
Invesco DB Base Metals Fund
DBB
$310M
$2K ﹤0.01%
135
– –
7 8
9
10 11

Similar funds

MPM
MBB Public Markets Chicago, Illinois $839M AUM 20.48% 1-Year Est. Return
SAIG
Semper Augustus Investments Group Highlands Ranch, Colorado $837M AUM 42.35% 1-Year Est. Return
CB
Community Bank Dewitt, New York $840M AUM 22.23% 1-Year Est. Return
WI
Walmart Inc Bentonville, Arkansas $840M AUM 140.45% 1-Year Est. Return
MWM
Marietta Wealth Management Marietta, Georgia $841M AUM 21.92% 1-Year Est. Return
DLP
De Lisle Partners Poole, United Kingdom $836M AUM 58.41% 1-Year Est. Return
BI
BBFIT Investments Singapore $842M AUM
MAP
Managed Asset Portfolios Rochester, Michigan $834M AUM 33.97% 1-Year Est. Return

Financial Enhancement Group's Q2 2018 Portfolio in Review

As of Q2 2018, Financial Enhancement Group held 285 positions worth $290M, up 2.4% from $284M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Financial Enhancement Group's Q2 2018 filing shows 19 new, 58 increased, 49 reduced and 26 closed positions. Its largest new stake was First Trust NYSE Arca Biotechnology Index Fund: 41,400 shares worth $5.8M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $8.67M.

By sector, the portfolio is most concentrated in Technology at 7.9% of assets, up from 7.8% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Financial Enhancement Group's largest Q2 2018 buy was First Trust NYSE Arca Biotechnology Index Fund: 41,400 shares worth $5.8M.
  • Financial Enhancement Group added most to First Trust Enhanced Short Maturity ETF in Q2 2018, an estimated $15.5M increase.
  • Financial Enhancement Group's biggest Q2 2018 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $8.67M.
  • Financial Enhancement Group fully exited Northrop Grumman in Q2 2018, selling an estimated $6.4M.
  • Financial Enhancement Group's ten largest holdings make up 53% of its $290M portfolio in Q2 2018.
  • Financial Enhancement Group opened 19 new positions and closed 26 in Q2 2018.
  • Financial Enhancement Group's portfolio value rose 2.4% quarter-over-quarter to $290M.

Based on Financial Enhancement Group's 13F filing for Q2 2018, filed 8 Aug 2018.